SageView Advisory Group’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$567K Buy
12,168
+612
+5% +$28.3K 0.02% 345
2026
Q1
$566K Sell
11,556
-27,782
-71% -$1.29M 0.02% 329
2025
Q4
$1.71M Sell
39,338
-603
-2% -$27.5K 0.06% 175
2025
Q3
$1.8M Buy
39,941
+28,759
+257% +$1.26M 0.06% 174
2025
Q2
$485K Sell
11,182
-2,492
-18% -$111K 0.02% 374
2025
Q1
$630K Buy
13,674
+1,299
+10% +$54.3K 0.03% 296
2024
Q4
$466K Buy
12,375
+2,479
+25% +$96.2K 0.02% 354
2024
Q3
$401K Sell
9,896
-1,196
-11% -$45K 0.02% 331
2024
Q2
$384K Buy
11,092
+1,099
+11% +$40.6K 0.02% 384
2024
Q1
$375K Sell
9,993
-173
-2% -$6.18K 0.02% 373
2023
Q4
$356K Buy
10,166
+570
+6% +$22K 0.02% 463
2023
Q3
$363K Buy
9,596
+218
+2% +$8.88K 0.02% 380
2023
Q2
$382K Buy
9,378
+310
+3% +$12.8K 0.02% 397
2023
Q1
$380K Buy
9,068
+299
+3% +$12.5K 0.02% 348
2022
Q4
$379K Buy
+8,769
New +$346K 0.03% 283

Other funds holding EXC

SageView Advisory Group's EXC Position: Q2 2026 in Review

SageView Advisory Group increased its Exelon (EXC) stake by 5.3% in Q2 2026, buying an estimated $28.3K and bringing the position to 12,168 shares worth $567K. The position accounts for 0.02% of the portfolio, ranked #345.

SageView Advisory Group first reported a position in EXC in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.8M in Q3 2025. 1,291 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • SageView Advisory Group held 12,168 shares of Exelon worth $567K as of Q2 2026.
  • SageView Advisory Group bought 612 Exelon shares in Q2 2026, an estimated $28.3K.
  • Exelon made up 0.02% of SageView Advisory Group's portfolio in Q2 2026, its #345 holding.
  • SageView Advisory Group first reported a position in Exelon in Q4 2022 and has held it in 15 quarters since.
  • SageView Advisory Group's Exelon position peaked at $1.8M in Q3 2025.
  • 1,291 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.